Table 3—

Perceived disability

Outcome variable and groupTest 1 (before treatment)Test 2 (after primary treatment and healing)Test 3 (8 months after primary treatment and healing)Post hoc within group over time testsANOVA group × test (P)
Physical functioning
 ATL31.8 ± 8.627.7 ± 6.828.1 ± 5.3*NS
 TCC31.7 ± 7.132.8 ± 8.738.9 ± 11.51 and 2 vs. 3P = 0.015
Role physical
 ATL40.3 ± 10.532.1 ± 13.735.9 ± 9.51 and 2 vs. 3
 TCC35.4 ± 11.535.4 ± 11.540.8 ± 10.41 vs. 3NS (0.085)
Bodily pain
 ATL43.9 ± 11.544.4 ± 10.642.9 ± 12.9NS
 TCC45.6 ± 10.644.9 ± 11.849.6 ± 8.5NSNS (0.64)
General health
 ATL39.7 ± 11.841.2 ± 11.836.3 ± 9.62 vs. 3
 TCC37.2 ± 11.137.8 ± 8.540.1 ± 11.2NS0.049
Vitality
 ATL48.1 ± 8.348.1 ± 12.945.8 ± 11.0NS
 TCC45.5 ± 10.944.4 ± 9.947.3 ± 11.7NSNS (0.45)
Social functioning
 ATL42.8 ± 12.440.2 ± 15.738.6 ± 16.3NS
 TCC40.8 ± 12.342.2 ± 11.844.9 ± 10.6NSNS (0.50)
Role emotional
 ATL45.9 ± 12.243.6 ± 13.845.1 ± 12.6NS
 TCC46.0 ± 14.146.0 ± 13.449.4 ± 10.2NSNS (0.88)
Mental health
 ATL48.4 ± 11.551.1 ± 12.050.0 ± 9.9NS
 TCC47.0 ± 7.543.7 ± 11.550.4 ± 10.1NSNS (0.56)
Physical summary score
 ATL35.5 ± 6.931.3 ± 8.031.0 ± 6.2*NS
 TCC33.9 ± 7.535.0 ± 7.739.4 ± 10.91 vs. 30.035
Mental summary score
 ATL51.2 ± 12.352.7 ± 15.551.6 ± 13.0NS
 TCC49.9 ± 11.348.2 ± 13.351.8 ± 11.5NSNS (0.56)
  • Data are means ± SD. Results from norm-based standardized SF-36 for ATL and TCC groups (1998 general U.S. population had a mean ± SD of 50 ± 10) (12).

  • *

    * Post hoc t test for group differences, ATL vs. TCC at given testing time (P < 0.05). ATL, n = 13; TCC, n = 12.